Algernon expects its soon-to-start ischemic stroke trial (phase 2a, ~50 patients) to cost only ~2 million CAD ($1.5 million USD)
$NWBO: ATL-DC IS DCVax-L - Part 2.
$NWBO: ATL-DC IS DCVax-L - part 1.
$NWBO: Flaskworks Eden. Outsmarting the competition
$nwbo
$NWBO Catalyst List Update 2023-24
Weekly Trader's Thread 1/15/24 - 1/21/24
Board moderation going forward
Weekly Trader's Thread 1/08/24 - 1/14/24
Sale of ATHX?
ATHX IP AND ALL sold to Healios....it's over
Form 8-K: Employees Termination
What VALUE should be considered by the FDA for MultiStem 90-95% APPLICABILITY for All Ischemic Stroke patients, versus Standard Of Care?...
$NWBO: TRY ... to suck up the beatings!
AVITA Medical's Better Mousetrap Rapidly Gaining Traction In Skin Repair (NASDAQ:RCEL)
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
(9/21/2023) CIRM Openness, the Neuro Task Force and a Public Comment
Board Closure?
8/22/23 My Letter (e-mail) to CIRM on Behalf of Athersys is Accepted!...And, will be forwarded to the Neuro Task Force...
REPORT: My 2nd Time (Call) with Dan Camardo - Thur., April 13, 2023...
What Comes Next For Athersys?
NICE and its changes as they may relate to $NWBO
Upcoming date tracker related to $NWBO
Should Adam be nervous??? $NWBO
IS THIS STILL JUST DOJ TALK? WHERE ARE THE INDICTMENTS? https://www.justice.gov/usao/justice-101/charging https://www.cohenmilstein.com/update/northwest-biotherapeutics-files-lawsuit-against-major-market-makers-market-manipulation $nwbo u/jhpratt2
